SIGNAPAIN F Tablet is an advanced fixed-dose combination designed to provide fast and effective relief from pain and inflammation. This formulation typically contains Diclofenac Potassium, Paracetamol (Acetaminophen), and Serratiopeptidase, a trio of potent and complementary agents known for their anti-inflammatory, analgesic, and anti-edematous properties.

Diclofenac Potassium is a non-steroidal anti-inflammatory drug (NSAID) that offers powerful pain relief by inhibiting prostaglandin synthesis through cyclooxygenase (COX) enzyme blockade. It rapidly reduces pain, swelling, and inflammation, making it effective in conditions like arthritis, lower back pain, sprains, and dental pain. Paracetamol, on the other hand, acts as a central analgesic and antipyretic, enhancing the pain-relieving action of Diclofenac without contributing to gastric irritation, thereby improving overall tolerability. Serratiopeptidase is a proteolytic enzyme that breaks down abnormal inflammatory proteins and edema, thus accelerating tissue healing and reducing swelling, bruising, and pain.

The synergistic action of these three components ensures that SIGNAPAIN F Tablet delivers rapid onset and prolonged duration of relief from pain, inflammation, and tissue swelling. It is particularly effective in managing musculoskeletal injuries, sports-related trauma, post-surgical pain, dental procedures, dysmenorrhea, and conditions involving soft tissue inflammation.

Manufactured by Bluepill Express in GMP-compliant, ISO-certified facilities, each batch of SIGNAPAIN F Tablet undergoes rigorous quality control, including stability testing, assay verification, and microbial analysis. The formulation is designed for optimal bioavailability and minimal gastrointestinal side effects, using high-quality excipients and film-coated tablets to ensure better patient compliance.

Bluepill Express ensures customized packaging options such as Alu-Alu or blister packs, tamper-proof sealing, and multilingual labeling as per the import regulations of each destination country. The product is offered under private label or contract manufacturing arrangements with complete documentation support including Certificate of Analysis (COA), MSDS, product dossier, and regulatory filings for semi-regulated and unregulated markets across Asia, Africa, Latin America, and the CIS region.

SIGNAPAIN F is suitable for adult patients who need reliable pain relief without sedation or narcotic dependency. The balanced combination allows for multiple daily doses without compromising patient safety. The product does not impair mental alertness, making it an excellent choice for ambulatory patients recovering from injuries, surgeries, or chronic inflammatory conditions.